Aetna Wun Trombley - President and CEO, Director, 10%+ Owner at Lycia Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Aetna Wun Trombley since 16 Nov 2025

Reported holdings for Aetna Wun Trombley in Lycia Therapeutics, Inc.

Form 4 holding President and CEO, Director, 10%+ Owner

Lycia Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
443,586
Estimated value
Report date
11 Aug 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director, 10%+ Owner

Lycia Therapeutics, Inc.

Security class
Common Stock
Shares / value
415,255
Estimated value
Report date
22 Oct 2026
Price
Ownership
By Trust

Transaction history for Aetna Wun Trombley in Lycia Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .